GOLM1 and hepatocellular carcinoma: In 2005, a study based on glycoproteomics screened serum glycoproteins and identified serum GP73 as a factor positively correlated with human hepatocellular carcinoma (HCC), which suggested that GP73 serves as a potential serum biomarker for HCC diagnosis (26).